Radiotherapy for metastatic prostate cancer-Authors' reply
Lancet
.
2019 Sep 7;394(10201):830.
doi: 10.1016/S0140-6736(19)31829-X.
Authors
Christopher C Parker
1
,
Nicholas D James
2
,
Christopher D Brawley
3
,
Noel W Clarke
4
,
Mahesh K B Parmar
3
Affiliations
1
Academic Urology Unit, Royal Marsden Hospital, London, SM2 5PT, UK. Electronic address: chris.parker@icr.ac.uk.
2
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
3
Medical Research Council Clinical Trials Unit at University College London, London, UK.
4
Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK.
PMID:
31498099
DOI:
10.1016/S0140-6736(19)31829-X
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Male
Prostatectomy
Prostatic Neoplasms / surgery*
Grants and funding
3804/CRUK_/Cancer Research UK/United Kingdom